Please use this identifier to cite or link to this item:
http://hdl.handle.net/11189/4475
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dave, Joel Alex Lex | - |
dc.contributor.author | Lambert, Estelle Victoria | - |
dc.contributor.author | Badri, Motasim A. | - |
dc.contributor.author | Maartens, Gary | - |
dc.contributor.author | Levitt, Naomi Sharlene | - |
dc.contributor.author | West, Sacha Jane | - |
dc.date.accessioned | 2016-06-29T08:39:42Z | - |
dc.date.available | 2016-06-29T08:39:42Z | - |
dc.date.issued | 2011 | - |
dc.identifier.uri | http://hdl.handle.net/11189/4475 | - |
dc.description.abstract | Background: Data on the prevalence of the complications of antiretroviral therapy (ART) (diabetes, central fat accumulation, peripheral fat wasting, and dyslipidemia) in sub-Saharan Africa are sparse. We examined the prevalence and associated risk factors of dysglycemia and insulin sensitivity in HIV-infected South Africans. Methods: HIV-infected patients, on nonnucleoside reverse transcriptase inhibitor-based ART or ART-naive, had oral glucose tolerance tests and clinical anthropometry. Insulin sensitivity and β-cell function were assessed. Results: The prevalence of dysglycemia in 406 ART-naive patients and 443 patients on ART was 25.7% and 21.9% (P = 0.193), respectively. Dysglycemic patients on ART had a similar body mass index (P = 0.440), greater waist circumference (P = 0.047), and smaller calf skinfold thickness (P = 0.015) than dysglycemic ART-naive patients but no difference in β-cell function or insulin sensitivity. Normoglycemic patients on ART had a greater body mass index (P = 0.0009), waist circumference (P = 0.0001), and abdominal skinfold thickness (P = 0.040), similar calf skinfold thickness (P = 0.079), and reduced β-cell function [lower insulinogenic index (P = 0.027) and oral disposition index (Do, P = 0.020)] compared with normoglycemic ART-naive patients. In multivariate analysis, older age [odds ratio (OR): 1.04, 95% confidence interval (CI): 1.02 to 1.06], male gender (OR: 1.96, 95% CI: 1.28 to 2.99), higher CD4 count (OR: 1.0, 95% CI: 1.00 to 1.02) and use of efavirenz (OR: 1.70, 95% CI: 1.19 to 2.45) were associated with dysglycemia. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Journal of Acquired Immune Deficiency Syndromes | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/za/ | en |
dc.subject | Antiretroviral therapy | en_US |
dc.subject | Diabetes | en_US |
dc.subject | Dysglycemia | en_US |
dc.subject | Human Immunodeficiency Virus (HIV) | en_US |
dc.subject | Impaired glucose metabolism | en_US |
dc.title | Effect of nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy on dysglycemia and insulin sensitivity in South African HIV-Infected Patients | en_US |
dc.type.patent | Article | en_US |
Appears in Collections: | BUS - Journal Articles (DHET subsidised) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Dave_Joel_Alex_Lex_Lambert_Estelle_Victoria_Ictoria_Badri_Motasim_A_Maartens_Gary_Levitt_Naomi_Sharlene_West_Sacha_Jane_Bus_2011.pdf | Main Article | 263.34 kB | Adobe PDF | View/Open |
Page view(s)
29
Last Week
0
0
Last month
0
0
checked on Feb 9, 2021
Download(s)
68
checked on Feb 9, 2021
Google ScholarTM
Check
This item is licensed under a Creative Commons License